AzTrials
AzTrials

Total Knee Arthroplasty; Total Hip ArthroplastyNCT03386786

Health Partner Evaluation at Princeton

A study testing Health Partner in people with Total Knee Arthroplasty; Total Hip Arthroplasty, run by DePuy Orthopaedics at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is a prospective, single-center, randomized, comparative, controlled study. Penn Medicine Princeton Medical Center will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Health Partner
Could I receive a placebo?
No, everyone receives an active treatment
How many people
127 participants
Where
1 siteUnited States
Study dates
30 Jun 2017to 11 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Subjects meeting all the following specific criteria will be considered for participation in the study:

  1. Subject is 18 years or older at the time of consent.
  2. Subject must be identified by their provider as needing elective unilateral TKA or THA.
  3. Subject must have a valid e-mail address and willing to access their inbox on a regular basis.
  4. Subject must possess a smartphone/device capable of downloading the current version of the Health Partner mobile app and be willing to access and use digital materials for this project.
  5. Subject must be able to comprehend and comply with the requirements of the study.
  6. Subject must be able to speak, read and understand English fluently.
  7. Subject is willing to give voluntary, written informed consent to participate in this service evaluation and authorize the transfer of his/her information to the Sponsor and Business Associate.

Subjects will be excluded from participation in the study if they meet any of the following criteria:

  1. Subject is not able to follow the standard of care and would require special care or circumstances.
  2. Subject scheduled to have TKA or THA less than or equal to 2 weeks (14 days) from the time they are enrolled in the study.
  3. Subject is undergoing a revision to a previous surgery.
  4. Subject is undergoing TKA or THA following traumatic injury (i.e. fracture).
  5. Subject is expected to need another lower limb joint replacement (hip/knee) prior to completing this service evaluation.
  6. Subject is a repeat patient and was enrolled in the study previously.
  7. Subject has had prior experience with the Health Partner companion app.
  8. Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
  9. Subject, in the opinion of their healthcare provider, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect his/her ability to complete patient reported questionnaires or be compliant with follow-up requirements.
  10. Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
  11. Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing activities (e.g., muscular dystrophy, multiple sclerosis, Charcot disease).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Penn Medicine Princeton Medical Center

    Plainsboro, New Jersey, 08536

Other trials in United States

About this study

Official title: Randomized, Controlled Evaluation of Health Partner mHealth for Total Joint Replacement at Penn Medicine Princeton Medical Center

This is a prospective, single-center, randomized, comparative, controlled study. Penn Medicine Princeton Medical Center will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment group (Health Partner alongside standard care) or the control group (standard care alone). Health Partner is a combination of a mobile application and a web-based portal. The primary objective is to compare care plan adherence (pre- and post-surgery) for Health Partner vs. control subjects. Secondary objectives include evaluating all-cause medical resource utilization, communication with health care provider, well-being, fear of surgery, confidence in recovery from surgery, sleep, and patient satisfaction for 90 days post-surgery.

Being tested
Health Partner, Standard Care
Keywords
Total Knee Arthroplasty, Total Hip Arthroplasty, Total Knee Replacement, Total Hip Replacement, Hospital Care Plan, mHealth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health PartnerBehavioural

    Also called mHealth

    Health Partner is a combination of a mobile application and a web-based portal.

  • Standard CareBehavioural

    Also called Control

    Patients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Princeton Healthcare System (PHCS).

Study groups in NCT03386786
Study groupRoleWhat they receive
Intervention (Health Partner)ExperimentalThe mobile health (mHealth) product, Health Partner for Knees and Hips (Health Partner), is a combination of a mobile application (app) and a web-based portal.
Receives: Behavioral: Health Partner
ControlOtherPatients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Princeton Healthcare System (PHCS).
Receives: Behavioral: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Care Path Behavioral Assessment (CPBA), Pre-surgery

    Survey assesses degree of subject adherence with pre-surgical activities

    Measured: Early post-operative (day after surgery to 6 weeks post-surgery)

  2. Care Path Behavioral Assessment (CPBA), Post-surgery

    Survey assesses degree of subject adherence with post-surgical activities

    Measured: Late post-operative (11-13 weeks post-surgery)

Secondary outcomes (10)
  1. Medical Resource Utilization

    Seven questions to evaluate the number and duration of encounters with the healthcare system after surgery

    Measured: Late post-operative (11-13 weeks post-surgery)

  2. Confidence in Recovery (1-item)

    One question to gauge subject's confidence in their recovery after surgery on a five-point Likert scale

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery)

  3. Fear of Surgery (1-item)

    One question to gauge degree to which subject is fearful of surgery on a five-point Likert scale

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to the day before surgery), early post-operative (day after surgery to 6 weeks post-surgery)

  4. Adherence (MOS Patient Adherence)

    The Medical Outcomes Study (MOS) Patient Adherence is a 5-item questionnaire gauging subject self-reported ability to follow doctors' suggestions and the frequency of subject adherence

    Measured: Early post-operative (day after surgery to 6 weeks post-surgery) and late post-operative (11-13 weeks post-surgery)

  5. Well-being (MQLI)

    The Multi-Cultural Quality of Life Index (MQLI) asks respondents to rank ten different areas of their life [self-care and independent functioning, occupational functioning, social-emotional support, community and service support, interpersonal functioning, global perception of quality of life, physical well-being, personal fulfillment, psychological/emotional well-being, and spiritual fulfillment] on a 10-point Likert scale

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

  6. Well-being (PHCS-WB)

    The Public Health Surveillance Well-Being Scale (PHCS-WB) comprises 10-items gauging self-reported mental, physical, and social components of well-being

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

  7. Sleep (MOS Sleep Scale)

    The Medical Outcomes Study (MOS) Sleep Scale is a 12-item instrument intended to gauge extent and nature of sleep disturbances

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

  8. Sleep (2-items)

    Two questions to assess whether subjects had 7-9 hours of restful sleep per night

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

  9. Communication (STAR-P)

    The STAR-P is a 12-item instrument to gauge subject's perceptions of clinical communication

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

  10. Communication (1-item)

    One question to assess the frequency of subject's communication with their provider

    Measured: Baseline (-6 to -3 weeks pre-surgery), pre-operative (-3 weeks to day before surgery), early post-operative (day after surgery to 6 weeks post-surgery), and late post-operative (11-13 weeks post-surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2017
  2. Study start30 Jun 2017
  3. Primary completion11 Dec 2019
  4. Study completion11 Dec 2019

Why it stopped: Business decision to close study due to slow enrollment.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
127 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03386786
Sponsor's protocol ID
DSJ_2017_01
Status last verified
Dec 2019
First submitted
2 Oct 2017
Last updated
2 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Health Partner in people with Total Knee Arthroplasty; Total Hip Arthroplasty, run by DePuy Orthopaedics at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 2 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Business decision to close study due to slow enrollment.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Care Path Behavioral Assessment (CPBA), Pre-surgery (time frame: Early post-operative (day after surgery to 6 weeks post-surgery)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in